Mechanism of action: Hydralazine balliculeVisual mnemonic: Hydralazine mascot “Hydraulic Ape pressure”
What it isArteriolar vasodilator of uncertain primary mechanism; resistant hypertension and, with nitrates, systolic heart failure.
Why this oneWith isosorbide dinitrate, improves heart-failure survival in Black patients; usable in pregnancy when RAAS blockers are not.
What limits itReflex tachycardia and fluid retention require companion therapy; frequent dosing hurts adherence. Long use can cause lupus and neuropathy.
Pearls
Cap maintenance at 200 mg/day to limit lupus risk.
Can aggravate angina; pair with a beta blocker and diuretic.
Molecular structure: Hydralazine
Hydralazine prescription history
Animated chart of estimated U.S. prescriptions per year, Antihypertensives (1953–2026). Hydralazine enters in 1953 (estimated).
FDA-approved for
hypertension (~1953)
Off-label
heart failure (with nitrates)
Principal riskReflex tachycardia; drug-induced lupus with prolonged use
Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.